PL4055191T3 - Diagnostyka różnicowa choroby afektywnej dwubiegunowej i nawracających zaburzeń depresyjnych za pomocą biomarkerów edycji rna we krwi - Google Patents

Diagnostyka różnicowa choroby afektywnej dwubiegunowej i nawracających zaburzeń depresyjnych za pomocą biomarkerów edycji rna we krwi

Info

Publication number
PL4055191T3
PL4055191T3 PL20800688.2T PL20800688T PL4055191T3 PL 4055191 T3 PL4055191 T3 PL 4055191T3 PL 20800688 T PL20800688 T PL 20800688T PL 4055191 T3 PL4055191 T3 PL 4055191T3
Authority
PL
Poland
Prior art keywords
biomarkers
blood
bipolar disorder
differential diagnosis
depressive disorders
Prior art date
Application number
PL20800688.2T
Other languages
English (en)
Other versions
PL4055191T4 (pl
Inventor
Dinah Weissmann
Nicolas Salvetat
Fabrice Chimienti
Original Assignee
Alcediag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcediag filed Critical Alcediag
Publication of PL4055191T3 publication Critical patent/PL4055191T3/pl
Publication of PL4055191T4 publication Critical patent/PL4055191T4/pl

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/165—Mathematical modelling, e.g. logarithm, ratio
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Zoology (AREA)
  • Data Mining & Analysis (AREA)
  • Molecular Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Pathology (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Evolutionary Computation (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
PL20800688.2T 2019-11-08 2020-11-09 Diagnostyka różnicowa choroby afektywnej dwubiegunowej i nawracających zaburzeń depresyjnych za pomocą biomarkerów edycji rna we krwi PL4055191T4 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19208126.3A EP3819387A1 (en) 2019-11-08 2019-11-08 Differential diagnosis of bipolar disorder and unipolar depression by blood rna editing biomarkers
PCT/EP2020/081459 WO2021089866A1 (en) 2019-11-08 2020-11-09 Differential diagnosis of bipolar disorder and unipolar depression by blood rna editing biomarkers

Publications (2)

Publication Number Publication Date
PL4055191T3 true PL4055191T3 (pl) 2024-12-16
PL4055191T4 PL4055191T4 (pl) 2024-12-16

Family

ID=68501512

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20800688.2T PL4055191T4 (pl) 2019-11-08 2020-11-09 Diagnostyka różnicowa choroby afektywnej dwubiegunowej i nawracających zaburzeń depresyjnych za pomocą biomarkerów edycji rna we krwi

Country Status (10)

Country Link
US (1) US20230272472A1 (pl)
EP (2) EP3819387A1 (pl)
JP (1) JP2023500847A (pl)
KR (1) KR20220094201A (pl)
CN (1) CN114945686A (pl)
CA (1) CA3155693A1 (pl)
ES (1) ES2992208T3 (pl)
IL (1) IL292588A (pl)
PL (1) PL4055191T4 (pl)
WO (1) WO2021089866A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3819386A1 (en) * 2019-11-08 2021-05-12 Alcediag Diagnosing of mood disorders using blood rna editing biomarkers
CN113604583B (zh) * 2021-08-10 2024-04-02 河南省畜牧总站 一种山羊kcnj15基因cnv标记辅助检测生长性状的方法及其专用试剂盒
WO2024038445A1 (en) * 2022-08-14 2024-02-22 Carmel Haifa University Economic Corporation Ltd. System and method of predicting disposition of a mental disorder of a subject
KR102808802B1 (ko) * 2022-09-02 2025-05-21 주식회사 비욘드디엑스 우울증과 양극성 장애 구분용 바이오마커 및 이의 용도
EP4389915A1 (en) 2022-12-21 2024-06-26 Alcediag Differential diagnosing of bipolar versus unipolar disorder in patient during depression phases using a to i rna editing znf267 gene
WO2025183250A1 (ko) * 2024-02-29 2025-09-04 주식회사 비욘드디엑스 우울증과 양극성 장애 구분용 바이오마커 및 이의 용도
WO2025233372A1 (en) * 2024-05-06 2025-11-13 Alcediag Method for differentiating patients across healthy control, bipolar disorder, schizophrenia, and schizoaffective groups
CN121041412A (zh) * 2024-05-30 2025-12-02 上海交通大学 细胞因子cxcl10在抑郁和/或焦虑障碍中的应用
CN119724545B (zh) * 2024-12-05 2025-09-23 南京利康医药科技有限公司 一种基于靶向代谢组学和机器学习模型的抑郁症疾病管理系统
CN119662807B (zh) * 2025-01-14 2025-11-28 江南大学 肺炎支原体肺炎感染重症度及并发症标记物及其在制备肺炎支原体感染诊断试剂盒中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2660765T3 (es) * 2004-06-21 2018-03-26 The Board Of Trustees Of The Leland Stanford Junior University Genes y rutas expresadas de forma diferencial en trastorno bipolar y/o trastorno depresivo mayor
WO2008066769A2 (en) * 2006-11-29 2008-06-05 Lohocla Research Corporation Genetic diagnosis of depression
ES2952748T3 (es) * 2007-06-13 2023-11-03 Alcediag Muestra de tejido periférico que contiene células que expresan el 5HTR2C y/o las ADAR como marcadores de la alteración del mecanismo de edición del ARNm de 5HTR2C y sus aplicaciones
EP2373999A4 (en) * 2008-12-09 2012-11-07 Stephanie Fryar-Williams NEW BIOMARKERS
CA2821651A1 (en) * 2010-12-20 2012-06-28 Cambridge Enterprise Limited Biomarkers
WO2015117204A1 (en) * 2014-02-06 2015-08-13 Immunexpress Pty Ltd Biomarker signature method, and apparatus and kits therefor
US20180017580A1 (en) * 2014-12-05 2018-01-18 Myriad Genetics, Inc. Biomarkers for distinguishing mood disorders
CA3016657A1 (en) * 2016-03-11 2017-09-14 Alcediag Algorithm and an in vitro method based on rna editing to select particular effect induced by active compounds
US11104953B2 (en) * 2016-05-13 2021-08-31 Children's Hospital Medical Center Septic shock endotyping strategy and mortality risk for clinical application
WO2018020042A1 (en) * 2016-07-28 2018-02-01 Alcediag Rna editing as biomarkers for mood disorders test
EP3819386A1 (en) * 2019-11-08 2021-05-12 Alcediag Diagnosing of mood disorders using blood rna editing biomarkers

Also Published As

Publication number Publication date
EP4055191C0 (en) 2024-07-03
EP3819387A1 (en) 2021-05-12
CN114945686A (zh) 2022-08-26
US20230272472A1 (en) 2023-08-31
PL4055191T4 (pl) 2024-12-16
WO2021089866A1 (en) 2021-05-14
CA3155693A1 (en) 2021-05-14
KR20220094201A (ko) 2022-07-05
IL292588A (en) 2022-06-01
ES2992208T3 (es) 2024-12-10
EP4055191B1 (en) 2024-07-03
EP4055191A1 (en) 2022-09-14
JP2023500847A (ja) 2023-01-11

Similar Documents

Publication Publication Date Title
PL4055191T4 (pl) Diagnostyka różnicowa choroby afektywnej dwubiegunowej i nawracających zaburzeń depresyjnych za pomocą biomarkerów edycji rna we krwi
PL4055190T3 (pl) Diagnozowanie zaburzeń nastroju za pomocą biomarkerów edycji rna we krwi
IL282233A (en) Nucleic acid constructs and methods of use
EP3472613A4 (en) DIFFERENTIAL DISEASE DIAGNOSIS SYSTEM AND METHOD
HRP20260212T1 (hr) Pripravci i postupci za liječenje mišićne distrofije
IL283149A (en) 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-one derivatives as hpk1 inhibitors for the treatment of cancer
EP2971132A4 (en) FABRIC AND BLOOD-BASED MIRNA BIOMARKERS FOR THE DIAGNOSIS, FORECASTING AND PREDICTING THE METASTAS POTENTIAL IN COLOR LECTAL CANCER
HRP20260034T1 (hr) Anti-btn3a antitijela i njihova upotreba u liječenju raka ili infektivnih poremećaja
MA43980A (fr) Méthodes de diagnostic et de pronostic de maladies et d'événements cardiovasculaires
EP3655160A4 (en) ORAL FLUID ANALYSIS CARTRIDGES AND METHODS OF USE
EP3411505A4 (en) EVIDENCE OF CANCER DEVELOPMENT AND DIAGNOSTICS
EP3512948A4 (en) ADMINISTRATION OF NUCLEIC ACIDS, PROTEINS AND SMALL MOLECULES IN GLASS-LIKE VESICULAR BODIES
CR20120248A (es) Inmunoglobulinas con dominio variable dual y usos de las mismas
IL311279A (en) Computer-implemented systems and methods for analyzing examination quality for an endoscopic procedure
EP3538135A4 (en) POLYTHERAPIES OF PREDNISONE AND URICASE MOLECULES AND THEIR USES
EP3714064C0 (en) METHODS AND KITS FOR DOUBLE-STRANDED DNA AMPLIFICATION
EP3997242A4 (en) Methods of detecting disease and treatment response in cfdna
EP4011441A4 (en) Method for increasing blood flow and metabolic rate of eye fundus
ATE520032T1 (de) Differentielle cytokinexpression bei einer menschlichen krebserkrankung
EP3740590C0 (en) LUNG CANCER DIAGNOSIS KITS AND METHODS
IL284885A (en) Method of characterization of visible and/or sub-visible particles in biologics
MA51823A (fr) Osimertinib destiné à être utilisé dans le traitement du cancer du poumon non à petites cellules
IL292186A (en) Compositions and methods for treating blood disorders
EP3679147C0 (en) 2-O-SULFATION ENZYME MUTANT AND 3-O-SULFATION ENZYME MUTANT, AND METHOD OF USE THEREOF
EP3968991C0 (en) PROTEIN KINASE INHIBITORS AND THEIR USES FOR THE TREATMENT OF DISEASES AND HEALTH PROBLEMS